Nephros (NEPH) Share-based Compensation Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Nephros | 38.93 Mn | 34.91 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.30% |
| Dec 31, 2025 | -9.06% |
| Sep 30, 2025 | -16.59% |
| Jun 30, 2025 | 62.51% |
| Mar 31, 2025 | -19.30% |
| Dec 31, 2024 | -37.88% |
| Sep 30, 2024 | -29.18% |
| Jun 30, 2024 | 18.47% |
| Mar 31, 2024 | -15.52% |
| Dec 31, 2023 | -19.05% |
| Sep 30, 2023 | 131.85% |
| Jun 30, 2023 | -27.41% |
| Mar 31, 2023 | 5.68% |
| Dec 31, 2022 | -6.12% |
| Sep 30, 2022 | -16.49% |
| Jun 30, 2022 | -31.29% |
| Mar 31, 2022 | 6.45% |
| Dec 31, 2021 | 37.28% |
| Sep 30, 2021 | 15.31% |
| Jun 30, 2021 | -6.71% |
| Mar 31, 2021 | 69.03% |
| Dec 31, 2020 | 23.37% |
| Sep 30, 2020 | 11.81% |
| Jun 30, 2020 | -42.20% |
| Mar 31, 2020 | 53.56% |
| Dec 31, 2019 | 4.80% |
| Sep 30, 2019 | 28.72% |
| Jun 30, 2019 | -32.49% |
| Mar 31, 2019 | 5.66% |
| Dec 31, 2018 | 17.94% |
| Sep 30, 2018 | -58.00% |
| Jun 30, 2018 | -1.97% |
| Mar 31, 2018 | 16.87% |
| Dec 31, 2017 | 4.25% |
| Sep 30, 2017 | -8.01% |
| Jun 30, 2017 | 0.55% |
| Mar 31, 2017 | 27.10% |
| Dec 31, 2016 | 8.57% |
| Sep 30, 2016 | 26.58% |
| Jun 30, 2016 | 21.32% |
| Mar 31, 2016 | -31.23% |
| Dec 31, 2015 | -54.23% |
| Sep 30, 2015 | 35.24% |